Patent Grant
10160966
The invention relates to preparation of samples for analysis, such as tissue or blood samples, or any other sample having nucleic acid (NA), (e.g. DNA or RNA).
Isolating and purifying NA of interest from a sample is a critical step in molecular biological applications in the fields of forensics, food safety, medicine etc. Sample lysis and whole nucleic extraction techniques are frequently complex; time consuming; require skilled technicians or robotics; require expensive consumables; and increase the risk of cross-contamination. Complexity poses problems for manual and automated systems alike with simpler systems often being more robust. Co-precipitation of salts (which may inhibit downstream chemical reactions) and NA overloading of glass microfiber filters when extracting from larger amounts of sample are common problems. Excessive DNA can inhibit PCR due to sequestering Mg2+ required for amplification. This limits the amount of a total NA extraction which can be used which is troublesome where the target DNA is relatively rare within the extraction. Total NA extraction is unnecessary for the majority of genetic testing. Purification of sequences of interest would be preferable in many cases. Additionally, many techniques work well (PCR) or even demand shorter NA templates (e.g. next generation sequencing).
Multiple liquid handling steps can result in loss or uneven extraction efficiencies of different DNAs or RNAs. μRNAs are becoming more important in early identification of disease due to changes in their expression, however μRNA-specific kits are expensive, and μRNA's may be lost in many extraction techniques due to their small size (18-24 bp). Poly(T) probes are sometimes used to selectively capture messenger RNA (mRNA) from total RNA extractions. The enriched fraction of mRNA may then be sequenced to analyse the relative expression of different genes (exome analysis). This expression profile contains valuable information for agricultural and medical diagnostics, or response of tissue cultures to novel drug therapies. However, mRNA is just 1-5% of total RNA (˜80% is ribosomal RNA), and current extraction methods are liable to lead to loss of rare material or to change the relative frequencies of different sequences. RNA, additionally, is particularly liable to damage, commonly by ubiquitous environmental RNAse. Simple and rapid extraction of target NA of interest (particular rare or vulnerable species such as mRNA) will improve the quality of analysis downstream. Finally, existing kits targeting mRNA are typically expensive (more than 25 per sample). Given developments in genetic analysis technology, such sample preparation costs are an important barrier to making these technologies available to users in the industrial and medical sectors.
US2003/0059789 (Efimov et al) describes oligonucleotide analogues, methods of synthesis and methods of use. It uses PNA in target enrichment.
US2004/0161788 (Chen et al) describes a sample processing tubule with three segments. It appears to describe a complex multi-reagent step, multi-chamber, and multi-valve system. A chelating agent, namely, EDTA is mentioned. This is apparently as an anti-coagulating agent in some examples, and in other examples it is used after DNA extraction during target enrichment.
Michele K. Nishiguchi et al: “DNA Isolation Procedures” 1 Jan. 2002, Birkhauser Basel, Basel ISBN 978-3-03-488125-8 pages 249-287 describes various DNA isolation procedures. This teaches several DNA isolation methods including adding a buffer comprising Chelex™ and EDTA, i.e. two chelating agents, to the sample and heating at 100 C for 12 min (p 265-266: “protocol 4”).
There is a requirement for an improved method and apparatus for simple, rapid NA extraction, which minimises the risks of cross-contamination and loss of NA during processing and sampling. Another objective is that there are fewer steps and less time for sensitive NA (especially RNA) to be damaged. Another objective is that it should target only the sequences of interest in large samples or mix of sequences, or the mRNA portion of total RNA. Another objective is that the method and apparatus be simple, repeatable and reproducible, and capable of effective sequence-specific target nucleic acid extraction and purification directly from a large mesofluidic sample with minimal user input.
The invention is directed towards achieving some or all of the above objectives
According to the invention, there is provided a method of preparing a nucleic acid sample for analysis with target enrichment, the method comprising the steps of:
According to another aspect of the invention, there is provided an apparatus for preparing a nucleic acid sample for analysis with target enrichment, the apparatus comprising a reaction vessel, a device for adding a chelating agent to a sample in the vessel until cells are lysed, to provide a crude lysate, and a device for providing a PNA probe at a concentration sufficient for binding and capture of discernible levels of target nucleic acid. The apparatus may also have features for performing any of the steps defined below.
In one embodiment, the sample is heated with the chelating agent.
In one embodiment, the method comprises the step of providing beads to which the PNA probes attach. Preferably, the beads are provided after the cells are lysed and the PNA probes have had time to bind to the target nucleic acid. In one embodiment, the beads are paramagnetic or magnetic. In one embodiment, the beads are in the size range of 50 nm to 5 μm.
In one embodiment, the PNA probe is attached to the inside of the reaction vessel or is in solution within the vessel. In one embodiment, the PNA probe and the crude lysate are brought into contact after the crude lysate cools to below a lysate annealing temperature (e.g. 63° C.).
In one embodiment, the step (a) is performed so that the target nucleic acid is sheared into fragments. In one embodiment, the sample is partially or fully caused to flow by magnetic attraction.
In one embodiment, the chelating agent concentration is in the range of 1% w/v to 20% w/v with respect to the sample.
In one embodiment, the chelating agent is a styrene-divinylbenzene co-polymer containing iminodiacetic acid groups, such as Chelex™ 100 resin (BioRad).
In one embodiment, the heating is at a temperature of 70° C. to 99.5° C., and preferably in the range of 98° C. to 99.5° C. for at least 5 minutes to provide a sample pH in the range of 10 to 11.
In one embodiment, the beads are magnetically removed after target nucleic acid has attached to the PNA probes. In one embodiment, the beads are removed on a surface in the magnetic field of the magnet. In one embodiment, the beads are removed in a recess or pocket of a body in the magnetic field of the magnet. In one embodiment, the pocket includes a carrier of oil or a wax. In one embodiment, the oil or wax is in liquid form during the reaction without application of a magnetic field, and is caused to solidify after the magnetic field has been applied and the beads have been attracted into the pocket. In one embodiment, the oil or wax is molten due to applied heating for lysing. In one embodiment, the oil or wax is located so that its temperature does not reach the lysing temperature, rather a lower temperature which causes the oil or wax to melt to free the beads.
Preferably, the oil or wax is located at the surface of the sample, and heating is applied at the lower end of the vessel, whereby the oil or wax remains on top of the surface while molten due to floating.
In one embodiment, the vessel is elongate and upright, heat is applied to the vessel at its lower end, and the oil or wax body is supported at or near the surface of the sample in the vessel.
In one embodiment, the oil or wax body is supported in a pocket at the lower end of an insert within the vessel, and the insert also comprises a magnetic device for applying and withdrawing a magnetic field.
In one embodiment, the insert has an internal conduit within which a magnet may be moved from a spaced-apart position to a position sufficiently close to the pocket so that it applies a magnetic field to the oil or wax body. In one embodiment, the wax or oil comprises a biphasic and thermomorphic body of oil or wax and water including an ionic liquid which varies in miscibility with water depending on a physical parameter such as temperature or pH.
In one embodiment, an anion or cation of an ionic liquid has a functional group which is the chelating agent, in which the functional group captures target cations from an aqueous solution when the ionic liquid is water miscible, and in which a change in physical parameters changes the miscibility of the ionic liquid, and in which the ionic liquid, functional group and any captured target analyte is shifted between phases, providing for removal.
In one embodiment, the anion or cation of the ionic liquid has a functional group which is a PNA, in which the functional group captures target nucleic acids from an aqueous solution when the ionic liquid is water miscible, and in which a change in physical parameters changes the miscibility of the ionic liquid, and in which the ionic liquid, functional group and any captured target analyte are shifted between phases in this manner, providing for extraction and purification of target analyte.
In another aspect, the invention provides a microbiological sample preparation apparatus comprising:
In one embodiment, the apparatus is configured for removing the support from the vessel to remove the beads as they are embedded in the wax or oil body after said body has re-solidified and/or because they are attracted to the support by a magnetic field.
In one embodiment, the magnetic device comprises a conduit within the support within which a magnet may be moved between a position proximate to the support lower end and a spaced-apart position. In one embodiment, the support has a pocket with a downwardly-facing open face within which the oil or wax body is engaged. In one embodiment, the apparatus comprises a device for analysing the analyte without removing the analyte.
Preferably, the support includes, at an upper end, said analysis device. In one embodiment, the analysis device includes a loop mediated amplification device. In one embodiment, the analysis device includes a capacitive sensor. In one embodiment, the analysis device includes an optical sensor.
In one embodiment, the support is a stem which is configured with a head for removing the sample from a material.
In one embodiment, the stem comprises a tip with a recess, at least one receiver in a side wall of the recess, and a guide in the recess for pressing material radially into the receiver as the tip is pressed into the material. In one embodiment, the guide is a distally-pointing spike and the receiver is an opening in the wall of the recess. In one embodiment, the head is separable from the stem being joined by an interlock which requires a friction fit of interlocking solid parts with solid wax in-between, but melting of the wax causing separation so that the head drops to a bottom of the vessel.
In another aspect, the invention provides a method of preparing a microbiological sample, the method comprising the steps of:
In one embodiment, the method comprises the step of removing the support from the vessel to remove the beads as they are embedded in the wax or oil body after said body has re-solidified and/or because they are attracted to the support by a magnetic field.
In one embodiment, the heating to lyse the sample occurs at a position in the vessel lower than the wax or oil plug, and said heating is sufficient to lyse the cells at a lower vessel level, and to melt the wax or oil at a higher vessel level. In one embodiment, the method comprises analysing the analyte without removing it from the vessel of the support.
The invention will be more clearly understood from the following description of some embodiments thereof, given by way of example only with reference to the accompanying drawings in which:—
The invention in some embodiments employs peptide nucleic acids (PNAs) as probes. PNAs are synthetic polymers with a N-(2-aminoethyl)-glycine backbone linked by peptide bonds and purine and pyrimidine bases bonded by a methylene bridge (—CH2-) and a carbonyl group (—(C═O)—) allowing them to engage in Watson-Crick bonding with other PNAs and NAs. PNAs were developed originally as a type of drug which would target messenger RNA and affect gene expression but later have shown value in NA hybridisation procedures. PNAs are resistant to extremes of pH and degradation by nucleases. The specificity of PNA probe binding allows shorter probes to be used also, making them particularly useful for the binding of μRNAs. As they have no charge, they do not need the benefit of cation screening to allow them to engage in Watson-Crick binding with PNAs or NAs.
Chelex™ extraction results in low ionic content. When ionic concentration is low, binding of two complementary nucleic acid strands is difficult as both have a negative charge and tend to repel each other without shielding of this charge by cations. This results in single stranded DNA and, prevents the use of DNA or RNA probes for target enrichment from Chelex™ extractions. This low ionic solution, the high pH and the shearing of NA during Chelex™ extraction are broadly considered serious disadvantages of this type of extraction. However, the problem is overcome, and these disadvantages turned to advantages, by using a PNA probe. PNA probes bind to complementary DNA and RNA sequences with high specificity, even in low-ionic/high-pH solution. The unusual but advantageous combination of Chelex™ extraction and PNA probes provides for a rapid, sequence-specific nucleic acid extraction procedure.
It is preferred that the timing of the steps is:
Referring to
The device 10 also comprises a rod 19 which is configured to move vertically through the bore 18, carrying a magnet 20 at its lower end. This allows the magnet 20 to come into close proximity to the wax plug 17 but separated by the short solid plastics gap between the bottom of the bore 18 and the recess 16.
As is described in more detail below, the wax plug 17 is formed of wax 25 within which are uniformly distributed magnetic beads 26 having a coating (e.g. streptavidin) to bind to a probe which is selected for attracting a target NA within the volume formed below the plug 17 within the tubular housing 11. This volume contains lysate and the wax plug 17 is a friction fit within the recess 16. The plug 17 is a disc-shaped body of wax 25 (e.g. molecular grade paraffin wax) within which are embedded the paramagnetic beads 26, a known composite of polystyrene and ferrite nanoparticles.
Sample Preparation Method Main Steps
The following describes a sample preparation method of the invention performed using the apparatus 1. Typical times for each step are given in parentheses. It will be appreciated that the method may alternatively be performed with use of a different apparatus, possible without some of the benefits of the apparatus 1 such as the closed environment throughout sample preparation.
A sample of interest is added to the vessel 11 containing Chelex™ 100 (5-20% w/v) and water (e.g. deionised water). The vessel is then capped 12. The sample may, for example, have a carrier liquid carrying an analyte and the liquid level is up to the base of the plug 17. (1 min)
As noted above, the streptavidin-coated paramagnetic beads 26 are held within the wax plug 17 in the pocket 16. The surface of the cap 12 and plug 17, as are now below the liquid level, are coated in lyophilised, biotinylated PNA probes complementary to the sequence of interest. The PNA probes then go into solution as they are freed from the surface. The lower end of the sealed vessel 11 is heated by the base 2 to 99° C., resulting in a crude lysate. Convective heating melts the wax 25 (e.g. greater than 60° C.) but the beads 26 are held in situ by the magnet 20 (5 mins).
The temperature at the base is reduced to the annealing temperature of the PNA probe and the NA of interest, allowing binding. This temperature is 63° C. (3 mins). The magnet 20 is removed and the higher density and hydrophilic beads 26 drop out of the wax plug 17 and enter into the lysate where they circulate and bind biotinylated PNA probes and any captured target NA. (5 mins). The magnet 20 is re-inserted through the bore 18 and the circulating beads 26 are re-captured at the top of the volume, generally within the recess 16 (1 min). Target NA are now safely transported by the beads (hence “T-beads”), and concentrated within the wax plug 17. The cap 12 is removed from the vessel 11, with the wax/bead. The PNA probe/target NA mixture is magnetically held within the recess 16. This is transported to an analysis station. Advantageously, because of the embedding in wax there is little chance of contamination. At the analysis station, separation is provided by PNA-NA Watson-Crick binding, biotin-streptavidin binding and paramagnetic beads (1 min).
It will be appreciated from the above that the entire sample preparation procedure was completed in about 15 minutes, and without opening the vessel 11 from the moment the sample was introduced. Also, the heating provides the effect of lysing at a lower part of the vessel 11 at a temperature of about 70° C. to 99.5° C., and preferably in the range of about 97° C. to about 99.5° C. However at the higher levels closer to the plug 17 the temperature is lower, about 55 to 65° C. This is sufficient to melt the wax to free the beads 26, but the wax remains on top as it is lighter than the underlying liquid and so floats. Also, the temperature differential provides mixing by way of convention within the vessel 11. This convection is sufficient to thoroughly mix the components to maximise contact of target NA with the probe and of the probe to the beads 26. However, this circulation is not sufficient to equalise the temperature. This is because the vessel 11 has a high aspect ratio.
In more detail, the paramagnetic beads (“T-beads”) 26 are of ˜2.8 μm diameter and are streptavidin-coated. In general it is preferred to have a bead size in the range of 100 nm to 5 μm.
The beads 26 are well dispersed within the wax 25. The cap is in a sterile packet. A pack of caps may also come in a sterile packet (e.g. X96).
Sequence-specific PNA probes are provided lyophilised on the surface of the recess 16 and the vessel 11.
The base 2 in this embodiment includes a Peltier device for heating and cooling.
The vessel 11 is of polypropylene SBS, is 2D barcoded, and is of 1.4 ml capacity. This tube has a height of 40 mm and an internal diameter of 8.5 mm and a wall thickness of 1 mm, and so is suitable for convective heating. The tube 11 is pre-filled with 1 ml (liquid column 29.5 mm high with 10.5 mm air above, range 100-1300 μl) of a lysis buffer containing 10% w/v (range 5-20%) Chelex™ 100 resin (BioRad). Chelex™ is a styrene-divinylbenzene co-polymer containing iminodiacetic acid groups. It helps to purify other compounds by ion exchange and can bind transition metal ions. Chelex™ solutions are alkaline (pH 8.4-10) and, this, together with heating (e.g. 99° C.) provide for efficient sample lysis. However, enzymes called nucleases which break down NA are also released in cell lysis. Chelex™ resin additionally scavenges metal ions required (cofactors) by the nucleases to function, protecting NAs from degradation. The user removes a foil seal and adds the sample (e.g. a narrow 1 μl plug of tissue taken with a unicore from a cattle carcass).
The single piece, injection-moulded, sterile, polypropylene cap 12 fits into the tube 11. The cap 12 has a screw head and rubber O-ring 14 (both 8.5 mm diameter) to seal firmly into the tube 11. The portion of the cap 12 screwed into the tube 11 is 11.5 mm in height and has a 7.0 mm external diameter. The recess 16 will, thus, be immersed in the lysis solution. The insert 15 is cylindrical of 3 mm diameter and extends 10.5 mm, with the base thus sealed from the lysis buffer. The rod 19 is manually inserted into the hole 18 and holds a small neodymium magnet 20 (e.g. Apex Magnets 12.0 mm×3.0 mm magnet). The recess 16 has a 7.0 mm external diameter, a 6.5 mm internal diameter and depth of 1 mm. The recess or pocket is filled with the plug 17 which is of suitable wax (e.g. Molecular Grade Paraffin Wax) which will melt at moderately high temperatures (e.g. >45° C.). The T-beads 26 are held in situ and prevented from clumping during storage by being dispersed within the solid wax 25. This removes the need for blocking and washing of beads before use, as may be a problem in many existing systems employing beads. The PNA probes are lyophilised on the surface of the plug 17 and cap 12.
The cap 12 is engaged with the tube 11, sealing the tube during the lysis step. The bottom end of the cap 12 is immersed in the lysate. This results in the lyophilised PNA probe entering into solution. The capped tube 11/12 is placed on the heating plate 2 at 99° C. An advantageous heat differential between the bottom and top of the tube occurs. Tissue in the 99° C. zone at the base is lysed. The top of the volume reaches a temperature of about 72° C. which readily melts the wax plug 17 but does not cause damage to the streptavidin. The beads 26 are held in situ by the magnet 20, protected from the high pH in the lysate. After a five minute lysis step and the release of NA, the temperature is dropped at the base of the tube to the annealing temperature of the PNA and NA of interest (e.g. 63° C.). Raleigh-Bénard convection and the presence of PNA and NA of interest in free solution provides for good reaction kinetics and PNA-NA binding during a three minute incubation step.
The wax 25 is still molten at this temperature. The rod 19 and the magnet 20 are removed. The higher density and hydrophilic nature of the T-beads 26 causes them to drop into the lysate. Convection of the T-beads, PNA probes and target NA provides for good reaction kinetics over a three minute incubation step. The biotinylated probes and bound target NA are captured on the streptavidin-coated T-beads. The rod 19 and the magnet 20 are re-engaged. T-beads 26 are drawn into the molten wax 25 by the external magnetic field as they flow around the lysate. After one minute, the tube 11 may be removed from the base plate 2. The wax 25 solidifies with the T-beads 26, PNA probes and target NA separated from the lysate and sealed safely within the wax. This enriched target NA can be stored safely, making it useful for bio-banking.
If required, the cap 12 can now be removed from the tube 11 and placed in another vessel. The encapsulation in wax helps prevent environmental contamination during transfer. The cap 12 is placed in a 0.5 ml 2D barcoded elution tube filled with deionised water at >80° C. The wax 25 will melt at this temperature. The rod 19 and the magnet 20 are disengaged. The beads 26 drop into the second tube where the PNA/NA Watson-Crick binding will melt and the NA is eluted. The beads are drawn back into the receptacle where they will again be captured in the wax.
The above assay and barcoded tube apparatus is particularly amenable to robotic automation, both for a single well design and a standard SBS footprint 96 well format. An array of the caps 12 can be screwed into racks of tubes 11, each containing sample. Similarly, an array of 96 rods 19 and magnets 20 can be automatically engaged and disengaged as required by the assay with a temperature-controlled baseplate.
Our invention rapidly extracts and concentrates target NA in a device which allows reproducibility, and ease of storage and transfer to other vessels. After sample addition, the user-friendly device is completely sealed during the few steps remaining to complete the procedure, reducing the risk of errors and cross-contamination. All reagents are integrated into the device.
In another embodiment, the elution vessel is replaced by an analytical vessel with which the recess 16 engages. In this embodiment, the wax is melted (>45° C.) to create a fluid-fluid interface through which the intact T-bead-PNA-NA complex is drawn into the analytical vessel. The single stranded nature of captured DNA means downstream reactions such as isothermal Loop-mediated amplification (LAMP) would not require an initial denaturation step. The base plate 2 can control isothermal LAMP at 60° C. if the analytical vessel were integrated into the cap 12.
In another embodiment, an extra set of beads (R-beads) with covalently bound probes for a second locus near (˜100-5000 bp) which is targeted by the probes on the T-bead may be included in the wax plug. This results in the second beads becoming tethered to the T-beads. This arrangement gives extra specificity and allows haplotype inference. The second beads are too small to overcome interfacial tension and are not drawn into the wax plug unless tethered to the T-beads. The number of R-beads captured in the wax pug (1106) in the removable sampling device is informative for downstream assays.
In another embodiment, the R-beads bind to distinct, complementary PNA probes on a multiple sensor silicon chip built into the device. The chip can be rinsed with deionised water without affecting PNA binding because PNA-DNA or PNA-PNA binding does not require the screening effect of cations. Isolated bead complexes can be stored in situ for bio-banking. The chip may be read later with the number of captured beads on each sensor conveying information on the number of each target NA present in the sample and relative concentration of each. The chip has enough sensitivity to detect captured beads (and hence captured NA) without any amplification of NA being required. This eliminates enzymatic steps (e.g. PCR), significantly simplifying the chemistry in this sample-preparation invention.
Referring to
Referring to
The head 105 is connected to the stem 101 by an interlock 115 (best illustrated in
The head 105 is pressed into the material and is twisted so that the tapered sides of the spike 107 force tissue 130 out into the windows 108, which grip it as the device is removed.
The device 100 is placed in a receptacle 120 as shown in
This apparatus 100, 120 has the advantage of acting initially as a sampling device to remove a small sample of material and then as a testing device. This makes the process of taking a sample simpler, speedier and safer, as metal scalpels and forceps are not required for taking the sample. It also standardises the amount of tissue removed, helping to also standardise the concentration of DNA and RNA in the lysate, which is useful for downstream analysis. Advantageously, all the components of the device 100, 120 are together upon sealing.
In various embodiment, the chelating agents (e.g. iminodiacetic acid) are functional groups of an ionic liquid (cf Pierre Bonhôte,*, Ana-Paula Dias, Nicholas Papageorgiou, Kuppuswamy Kalyanasundaram, and Michael Grätze (1996) Inorganic Chemistry 35 (5), 1168-1178) which is denser than water and forms a bi-phasic system at room temperature but is miscible at higher temperatures. The chelated cations (e.g. Ca2+ and Mg2+) are retained in a layer which is denser than the aqueous lysate.
In one embodiment, a PNA probe is the functional group of an ionic liquid of an ionic liquid (cf Bonhote 1996) which has a different density than water and forms a bi-phasic system at room temperature but is miscible at higher temperatures.
It will be appreciated that the invention provides a method and apparatus that are simple and involve low risk of cross-contamination. They involve only low volumes, with simple, rapid and self-contained lysis.
The use of a chelating agent with a PNA probe is surprisingly advantageous. Many techniques won't work satisfactorily with a Chelex extraction, for example Restriction fragment length polymorphism. Chelex extraction is known to work in PCR because this can use single stranded and somewhat sheared DNA as a template. The small amount added (1:20) doesn't affect the PCR chemistry most of the time.
The simplicity of our embodiments, with minimal steps and a single tube extraction preventing loss of targets, rapidity, and the use of a chelating agent on a denser material such as a resin which means the nuclease co-factors and chelating agent are retained in the vessel are all clear advantages. The low ionic solution and high pH helps prevent NA binding to NA, including hairpins and loops, and ensures that any target NA is available to a probe. The low-ionic solution and high pH is traditionally considered a disadvantage to Chelex™ extractions and has limited its popularity in the field. However, in our invention this environment ensures that only the PNA probe, with its neutral backbone and resistance to high pH, can bind to the target. A standard DNA, RNA (or RNA derivative) probe will not bind to a target in these conditions, i.e. our assay is highly specific. Selective transport and storage of target NA by the paramagnetic beads would not be possible without the very unusual use of PNA probes with Chelex™, exploiting a feature which is ordinarily considered a distinct disadvantage of Chelex™.
A preferred embodiment of the invention involves the introduction of PNA probes prior to the introduction of the streptavidin-coated beads. This PNA is free to circulate in the lysate and bind to any target NA. This improves kinetics and speed of the procedure. This apparatus allows for maintenance of separation of the beads from the lysate and the biotinylated target until the appropriate time has elapsed. This is then accomplished by removal of a magnetic field, releasing the beads into the lysate. This allows control of the kinetics of the procedure without opening the tube.
The invention is not limited to the embodiments described. For example, the mechanism of using a chelating agent with PNA probes may be used in a more manual method without particular apparatus such as the apparatus 1. Also, it is not essential that the beads be embedded in wax. They could alternatively be provided lyophilised or in a gel plug. Also, it is not essential that the beads are removed from the vessel for analysis. In this case the analysis takes place in situ. The analysis means may for example be within the cap. In this case the magnetic mechanism may be arranged to convey the beads to an upper chamber for analysis, possibly through an annular passage in the support. These embodiments have the benefit of keeping everything within the same closed environment throughout.
Also, the apparatus of any embodiment may be used with samples having analytes other than NA, such as proteins, bacteria, or other microbiological entities.
| Number | Date | Country | Kind |
|---|---|---|---|
| 13197017 | Dec 2013 | EP | regional |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/EP2014/077168 | 12/10/2014 | WO | 00 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2015/086652 | 6/18/2015 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 6428962 | Naegele | Aug 2002 | B1 |
| 8623636 | Fernandez Lopez | Jan 2014 | B2 |
| 20030059789 | Efimov et al. | Mar 2003 | A1 |
| 20040086944 | Grigg | May 2004 | A1 |
| 20040161788 | Chen et al. | Aug 2004 | A1 |
| 20110124851 | Guo | May 2011 | A1 |
| Number | Date | Country |
|---|---|---|
| 1 944 368 | Jul 2008 | EP |
| WO 2006071770 | Jul 2006 | WO |
| Entry |
|---|
| Walsh et al, Chelex 100 as a Medium for Simple Extraction of DNA for PCR-Based Typing from Forensic Material, 1991, BioTechniques, 10, 506-513 (Year: 1991). |
| Vaara, Maarti; “Agents That Increase the Permeability of the Outer Membrane”; Microbiological Reviews; vol. 56, No. 3; Sep. 1992; pp. 395-411. |
| International Search Report issued in PCT/EP2014/077168; dated Mar. 2, 2015. |
| Michele K. Nishiguchi et al.; “DNA Isolation Procedures”; Methods and Tools in Biosciences and Medicine, Techniques in molecular systematics and evolution; 2002; pp. 249-287; Birkháuser Verlag Basel/Switzerland. |
| International Preliminary Report on Patentability and Written Opinion of the International Searching Authority; PCT/EP2014/077168 dated Jun. 14, 2016. |
| http://www.bio1000.com/experiment/biochemica1/241859.html; “Bio Information, Mechanism and Steps of Separating and Purifying DNA with Magnetic Beads”; 3 pp.; May 22, 2012. |
| Office Action issued by the Chinese Patent Office dated Jul. 24, 2018 for Chinese Patent Application No. 201480075445.4; 12 pp. |
| Number | Date | Country | |
|---|---|---|---|
| 20160298107 A1 | Oct 2016 | US |
